Metformin Regulates Cardiac Ferroptosis to Reduce Metabolic Syndrome-Induced Cardiac Dysfunction
Applied Biochemistry and Biotechnology · 2025-01 · 197 (1) · 179-193
DOI: 10.1007/s12010-024-05038-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Biochemistry and Biotechnology, online erschienen am 06.08.2024. Verfasst von Liancheng Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Suqian First Hospital, No.120 Suzhi Street, Suqian, 223800, Jiangsu Province, China. Hauptthemen laut MEDLINE: Metformin, Ferroptosis, Metabolic Syndrome, Myocardium. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Suqian Sci&Tech Program.
Abstract (Originalsprache)
High-fat diet-induced metabolic syndrome (MetS) is closely associated with cardiac dysfunction. Recent research studies have indicated a potential association between MetS and ferroptosis. Furthermore, metformin can alleviate MetS-induced cardiac ferroptosis. Metformin is a classic biguanide anti-diabetic drug that has protective effects on cardiovascular diseases, which extend beyond its indirect glycemic control. This study aimed to assess whether MetS mediates cardiac ferroptosis, thereby causing oxidative stress and mitochondrial dysfunction. The results revealed that metformin can mitigate cardiac reactive oxygen species and mitochondrial damage, thereby preserving cardiac function. Mechanistic analysis revealed that metformin upregulates the expression of cardiac Nrf2. Moreover, Nrf2 downregulation compromises the cardio-protective effects of metformin. In summary, this study indicated that MetS promotes cardiac ferroptosis, and metformin plays a preventive and therapeutic role, partially through modulation of Nrf2 expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Suqian First Hospital, No.120 Suzhi Street, Suqian, 223800, Jiangsu Province, China.
- Fujian Medical University, Fuzhou, 350108, China.
- Department of Nephrology, Suqian First Hospital, Suqian, 223800, China.
- Department of General Surgery, Suqian First Hospital, No.120 Suzhi Street, Suqian, 223800, Jiangsu Province, China. sqyy1035@163.com.
Förderung
- Suqian Sci&Tech Program
Zitieren
APA
Xu, L., Li, W., Chen, Y., Liu, S., Liu, G., Luo, W., Cao, G., & Wang, S. (2025). Metformin Regulates Cardiac Ferroptosis to Reduce Metabolic Syndrome-Induced Cardiac Dysfunction. Applied Biochemistry and Biotechnology, 197(1), 179-193. https://doi.org/10.1007/s12010-024-05038-7
Vancouver
Xu L, Li W, Chen Y, Liu S, Liu G, Luo W, et al. Metformin Regulates Cardiac Ferroptosis to Reduce Metabolic Syndrome-Induced Cardiac Dysfunction. Applied Biochemistry and Biotechnology. 2025;197(1):179-193. doi:10.1007/s12010-024-05038-7
BibTeX
@article{Xu2025,
author = {Xu, Liancheng and Li, Wenwen and Chen, Yu and Liu, Shan and Liu, Guodong and Luo, Weihuan and Cao, Guanyi and Wang, Shiping},
title = {Metformin Regulates Cardiac Ferroptosis to Reduce Metabolic Syndrome-Induced Cardiac Dysfunction},
journal = {Applied Biochemistry and Biotechnology},
year = {2025},
volume = {197},
number = {1},
pages = {179--193},
doi = {10.1007/s12010-024-05038-7}
}
EUVIMED